// July 27, 2022
Learn how we are adapting lessons from the COVID-19 pandemic to help ensure greater global supply chain resilience.
// July 11, 2022
The problem of AMR is likely to have become significantly worse with the reportedly massive inappropriate use of antibiotics over the course of the COVID-19 pandemic, along with the likely increase in the prevalence of poor-quality antimicrobials resulting from supply chain quality concerns.
// June 23, 2022
Learn how medicine quality affects antimicrobial resistance and the medicines supply chain
// June 22, 2022
Impurities are any components that are not active ingredients or excipients, and that can compromise quality in a drug substance or product. Pharmaceutical impurities can be classified as organic or inorganic and include residual solvents. The presence of impurities results from manufacturing and degradation processes.